STRATA Skin Sciences (NASDAQ:SSKN) Issues Quarterly Earnings Results, Misses Estimates By $0.73 EPS

STRATA Skin Sciences (NASDAQ:SSKN) announced its quarterly earnings data on Thursday. The medical device company reported ($1.13) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.73), Zacks reports. The company had revenue of $33.56 million for the quarter, compared to the consensus estimate of $9.03 million. STRATA Skin Sciences had a negative net margin of 28.72% and a negative return on equity of 69.33%.

STRATA Skin Sciences Stock Up 1.1 %

NASDAQ:SSKN opened at $2.64 on Friday. The company has a debt-to-equity ratio of 1.62, a current ratio of 1.13 and a quick ratio of 0.94. The firm has a market cap of $11.01 million, a PE ratio of -0.99 and a beta of 1.32. The company has a 50-day moving average of $2.75 and a 200 day moving average of $2.92. STRATA Skin Sciences has a 1-year low of $2.51 and a 1-year high of $5.90.

Analyst Upgrades and Downgrades

Separately, Maxim Group began coverage on STRATA Skin Sciences in a report on Thursday, February 27th. They issued a “buy” rating and a $6.00 price target for the company.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.